Word: barres
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...natural habitats 2. Justice Fortas 3. Inits. on rebel uniforms 4. O.K. Corral figure 5. Ivory __, where coup rumors abound 6. Einstein's birthplace 7. The A.E.F. went Over There to win it 8. Senator Tom, who wants to limit teen work hours 9. "Got two fives for __?" 10. Barr's Cabinet successor 11. Guitar bar 16. Robert Conrad wants him investigated 20. Meat-loaf serving 21. __ Nagila 22. River to the Baltic 24. Taper off 25. Treasure Island monogram 26. Explorer Hernando de __ 28. Refusenik's refusal 30. Form 1040 deduction 31. 401(k) cousins 32. First name...
...other states, the brand-name companies have retained the upper hand. DuPont's allies in Florida, for instance, killed this year's effort by its rival Barr to let pharmacists substitute generics, including its blood thinner warfarin, for four brand-name drugs unless a doctor objects. Minutes after the state senate passed a bill backing Barr's plan in April, a flotilla of DuPont lobbyists converged on Speaker John Thrasher's office. Thrasher had earlier asked Republicans studying the bill to oppose it. Now he refused to let it come up for a vote. With the clock running, allies...
...three years running, DuPont has managed to shut Barr out. This month it quashed a bill that would have made it easier for Florida patients to get generic substitutes for certain brand-name prescriptions. As a result, Floridians are paying at least 25% more for their blood-thinning medication than they would if they had access to the generic version. And the cost of the drug keeps going...
Three years ago in North Carolina, DuPont helped ram through the legislature a bill requiring doctor's approval for the substitution of generics like Barr's warfarin. "We are only concerned about patient safety," says DuPont spokesman Thomas Barry. Some physicians support DuPont's position because they say warfarin is a tricky drug and doses must be carefully calibrated. The implication is that the brand names do a better job of that. But the FDA says the generic version is safe and has admonished DuPont more than once for stoking false fears in its promotion of Coumadin...
...generic-drug makers feel as if they're playing a game of 50-state Whack-a-Mole, never knowing where another amendment or rule pushed by their rivals is going to pop up. Take Illinois: last year Barr and its allies persuaded legislators to dissolve a state panel that had delayed marketing of some FDA-approved generics, but Governor George Ryan vetoed the bill. Still, all sides worked out a compromise to give immediate approval to most generics. Barr's lobbyists relaxed. Too soon, it turns out. A month ago, an amendment was quietly tacked onto a new bill...